Diabetes drug Metformin tests negative for NDMA, will not be recalled by FDA
With all of the medication recalls lately, it would have been wise for diabetic patients to wonder if their prescribed drug was next. Well the U.S. Food and Drug Administration actually released some good news this week, there are currently “no plans to recall any Metformin products.”
The testing follows multiple recalls of heartburn & high blood pressure medications the last couple years. More than 25 million Americans have Type 2 diabetes, and according to medscape.com, Metformin is the fourth most-prescribed drug in the United States. In their tests of the Type-2 Diabetes drug, the FDA found no evidence of N-nitrosodimethylamine (NDMA) at levels that would cause concern. In fact, the results of their testing found that the levels of NDMA in Metformin were “not detectable to low”.
This doesn’t close the book on NDMA in diebetic medications. The FDA says that it will “continue to monitor NMDA in Metformin along with other drug products.” For those that still have concerns, the FDA wants to make it clear to Metformin prescription patients that they should not stop taking the drug without first speaking with their health care provider.
To read the full Medscape's full FDA report on Metformin, click here: https://wb.md/2SsiVVy